PUBLISHER: IMARC | PRODUCT CODE: 1540782
PUBLISHER: IMARC | PRODUCT CODE: 1540782
Cell Analysis Market Report by Product, Analysis Type, Techniques, End-User, and Region 2024-2032
The global cell analysis market size reached US$ 20.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 40.1 Billion by 2032, exhibiting a growth rate (CAGR) of 7.4% during 2024-2032. The shift towards personalized medicine, increasing cases of cancer across the globe, and growing integration of artificial intelligence and machine learning in cell analysis are some of the key factors, catalyzing the growth of the market.
Cell Analysis Market Analysis:
Major Market Drivers: Increasing demand for cell analysis tools in drug discovery and development, particularly in fields like oncology and immunology, is primarily driving the market growth. The rising prevalence of chronic diseases like cancer and autoimmune disorders is augmenting the need for advanced cell analysis techniques for disease diagnosis and treatment, which is also contributing to the market growth.
Key Market Trends: The expansion of regenerative medicine and stem cell research is augmenting the need for cell analysis tools to study cell behavior, differentiation, and therapeutic applications, which is creating a positive outlook for the overall market.
Competitive Landscape: Some of the leading cell analysis companies operating in the global market include Agilent Technologies Inc., BD Biosciences, Bio-RAD Laboratories Inc., Danaher Corporation, Illumina Inc., Merck KGaA, Miltenyi Biotec, Olympus Corporation, PerkinElmer Inc., Promega Corporation, Sysmex Corporation, and Thermo Fisher Scientific, among others.
Geographical Trends: According to the report, North America currently dominates the global market. The growth of the region can be attributed to the increase in incidences of cancer and rising corporate and government funding in cell-based research activities.
Challenges and Opportunities: Challenges include the complexity of interpreting large-scale data, maintaining cell viability during analysis, and the high cost of advanced technologies. Opportunities lie in expanding applications in personalized medicines, regenerative therapies, and the integration of artificial intelligence to enhance analytical capabilities and streamline processes.
Global Cell Analysis Market Trends:
Growing Burden of Cancer
The rising number of cancer cases across the world is primarily driving the market growth. Cell analysis tools and techniques in cancer research enable precise characterization of tumor cells, including their genetic mutations, protein expression profiles, and cellular interactions within the tumor microenvironment. The growing number of cancer patients is catalyzing the cell analysis market share. For instance, as per an American Cancer Society 2022 update, around 1,918,030 new cancer cases were estimated in the U.S. in 2022. Furthermore, lung cancer and breast cancer are two of the most common cancers found among individuals. The Canadian Cancer Society (CCS) stated that in 2020, nearly 29,800 Canadians were diagnosed with lung cancer, which accounted for 13% of all new cancer cases. About 21,200 Canadians were expected to die from lung cancer, which represented 25% of all cancer deaths in 2020. This indicates an inflating need for effective and more advanced cancer cell analysis. Thus, the increasing demand for effective and lasting cancer treatment is anticipated to offer lucrative growth opportunities to the overall market.
Increasing Development of Novel Molecules
The rising prevalence of various infectious diseases is prompting the development of novel molecules and vaccines, which in turn is augmenting the cell analysis market revenue. Cell analysis tools play a crucial role in drug discovery and development by enabling researchers to assess the efficacy, safety, and mechanism of action of potential drug candidates. Furthermore, various pharmaceutical and biotech firms are increasingly relying on cell analysis techniques and tools to introduce new and improved drugs. For instance, according to the data published by the Congressional Budget Office, in 2021, it was observed that pharmaceutical industries spent nearly US$ 200 Billion on research and development in 2020 globally, compared to US$ 83 Million in 2019. Similarly, Danaher Corporation invested US$ 1,742 million in its research and development in 2021, as compared to US$ 1,348 Million in 2020. In addition, Bio-Rad Laboratories Inc., invested US$ 879.6 Million in 2021 as compared to US$ 800.3 Million in 2020. Thus, the rising investment in research and development by the companies further increases the capabilities of the company to adopt innovative cell analysis techniques, thereby propelling the cell analysis market growth.
Rising Number of Strategic Collaborations and Acquisitions
Various key market players are forming partnerships and collaborations to develop new and improved cell analysis methods, tools, and techniques. For instance, in August 2022, DeNovix Inc., the manufacturer of the award-winning CellDrop Automated Cell Counter, developed two dedicated nuclei counting apps capable of differentiating isolated nuclei and intact cells from debris. The CellDrop Series is a line of image-based, automated cell counters. Systems include a high-definition 7-inch touchscreen for live preview and instant review of results. Similarly, in November 2022, Sony Corporation launched the SFA - Life Sciences Cloud Platform, a flow cytometry data analysis cloud solution that can quickly identify rare cells, such as cancer cells and stem cells, from a wide variety of cell populations, using data obtained from flow cytometers. In addition to this, in March 2022, Thermo Fisher Scientific introduced a new large-volume electroporation system that is intended to enable the development of cell therapies. Such innovations are expected to bolster the cell analysis market demand in the coming years.
Global Cell Analysis Industry Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global cell analysis market report, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on product, analysis type, techniques, and end-user.
Breakup by Product:
Breakup by Analysis Type:
Breakup by Techniques:
Breakup by End-User:
Breakup by Region:
Competitive Landscape:
The competitive landscape of the industry has also been examined with the detailed profiles of the following key players:
Global Cell Analysis Market News:
Key Questions Answered in This Report
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
3 Executive Summary
4 Introduction
5 Global Cell Analysis Market
6 Market Breakup by Product
7 Market Breakup by Analysis Type
8 Market Breakup by Techniques
9 Market Breakup by End-User
10 Market Breakup by Region
11 SWOT Analysis
12 Value Chain Analysis
13 Porters Five Forces Analysis
14 Competitive Landscape
List of Figures
- Figure 1: Global: Cell Analysis Market: Major Drivers and Challenges
- Figure 2: Global: Cell Analysis Market: Sales Value (in Billion US$), 2018-2023
- Figure 3: Global: Cell Analysis Market: Breakup by Product (in %), 2023
- Figure 4: Global: Cell Analysis Market: Breakup by Analysis Type (in %), 2023
- Figure 5: Global: Cell Analysis Market: Breakup by Techniques (in %), 2023
- Figure 6: Global: Cell Analysis Market: Breakup by End-User (in %), 2023
- Figure 7: Global: Cell Analysis Market: Breakup by Region (in %), 2023
- Figure 8: Global: Cell Analysis Market Forecast: Sales Value (in Billion US$), 2024-2032
- Figure 9: Global: Cell Analysis (Flow Cytometry Products) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 10: Global: Cell Analysis (Flow Cytometry Products) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 11: Global: Cell Analysis (qPCR Products) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 12: Global: Cell Analysis (qPCR Products) Market Forecast: Sales Value (in Million US$), 2024-2032
List of Tables
